Showing results (1821-1830 of 1,914) with videos related to

Sort By:
Pageof 192
Nature Reviews. Urology|June 27, 2020
Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer researchMuhammad Imran Omar, Monique J Roobol, Maria J Ribal, et al.
Advances in Radiation Oncology|June 1, 2022
Development and Optimization of a Machine-Learning Prediction Model for Acute Desquamation After Breast Radiation Therapy in the Multicenter REQUITE CohortMahmoud Aldraimli, Sarah Osman, Diana Grishchuck, et al.
The Lancet. Respiratory Medicine|November 10, 2021
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trialJozefien Declercq, Karel F A Van Damme, Elisabeth De Leeuw, et al.
Nature|January 14, 2021
Local immune response to food antigens drives meal-induced abdominal painJavier Aguilera-Lizarraga, Morgane V Florens, Maria Francesca Viola, et al.
Clinical and Translational Radiation Oncology|July 25, 2026
Early and late CTCAE and patient-reported outcomes following prostate radiotherapy in the REQUITE cohortPhilipp Heumann, Juan Camilo Rosas Romero, Miguel E Aguado Barrera, et al.
Frontiers in Oncology|November 12, 2020
A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National CohortMichela Carlotta Massi, Francesca Gasperoni, Francesca Ieva, et al.
Lung Cancer (Amsterdam, Netherlands)|December 31, 2024
Professional-patient discrepancies in assessing lung cancer radiotherapy symptoms: An international multicentre studyMiguel E Aguado-Barrera, Carlos Lopez-Pleguezuelos, Antonio Gómez-Caamaño, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 25, 2022
Use of angiotensin converting enzyme inhibitors is associated with reduced risk of late bladder toxicity following radiotherapy for prostate cancerSarah L Kerns, Ashley Amidon Morlang, Sharon M Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|March 25, 2022
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)Lotte Van der Weijst, Miguel E Aguado-Barrera, David Azria, et al.
Science Immunology|January 30, 2026
Cross-species cellular mapping and humanization of Fcγ receptors to advance antibody modelingKarel F A Van Damme, Dorine Sichien, Katrien Van der Borght, et al.
Pageof 192